Single-Drug Approach with Edoxaban is Effective for Resolving Non-Acute Cancer-Associated Venous Thrombosis: A Single-Arm Retrospective Analysis.

Toshima, Hirokazu; Hisamatsu, Atsushi; Kobayashi, Kouji; Ishida, Hiroo; Shimada, Ken

Toshima, Hirokazu; Hisamatsu, Atsushi; Kobayashi, Kouji; Ishida, Hiroo; Shimada, Ken.

Afiliação

Toshima H; Medical Oncology, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan.
Hisamatsu A; Medical Oncology, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan.
Kobayashi K; Medical Oncology, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan.
Ishida H; Medical Oncology, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan.
Shimada K; Medical Oncology, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-chuo, Tsuzuki-ku Yokohama-shi, Kanagawa 224-8503, Japan.

Cancers (Basel) ; 12(7)2020 Jun 28.

Article em En | MEDLINE | ID: mdl-32605234

Palavras-chave

D-dimer; DOAC; cancer-associated venous thrombosis; deep-vein thrombosis; edoxaban; pulmonary embolism; single-drug approach; venous thromboembolism

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google